FMDRX
Price
$33.42
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
NQGCX
Price
$35.24
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
Ad is loading...

FMDRX vs NQGCX

Header iconFMDRX vs NQGCX Comparison
Open Charts FMDRX vs NQGCXBanner chart's image
Franklin Mutual Global Discovery R6
Price$33.42
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Nuveen Global Equity Income C
Price$35.24
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FMDRX vs NQGCX Comparison Chart
Loading...
VS
FMDRX vs. NQGCX commentary
Sep 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FMDRX is a StrongBuy and NQGCX is a Buy.

FUNDAMENTALS
Fundamentals
FMDRX has more cash in the bank: 9.44B vs. NQGCX (136M). NQGCX pays higher dividends than FMDRX: NQGCX (1.60) vs FMDRX (1.51). FMDRX was incepted earlier than NQGCX: FMDRX (11 years) vs NQGCX (15 years). FMDRX is a more actively managed with annual turnover of: 35.47 vs. NQGCX (29.00). NQGCX has a lower initial minimum investment than FMDRX: NQGCX (3000) vs FMDRX (1000000). NQGCX annual gain was more profitable for investors over the last year : 18.49 vs. FMDRX (9.15). NQGCX return over 5 years is better than : 48.79 vs. FMDRX (11.99).
FMDRXNQGCXFMDRX / NQGCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years15 years-
Gain YTD8.29011.83970%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets9.44B136M6,938%
Annual Yield % from dividends1.511.6095%
Returns for 1 year9.1518.4949%
Returns for 3 years3.6519.5319%
Returns for 5 years11.9948.7925%
Returns for 10 years0.4844.261%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LIND10.620.47
+4.63%
Lindblad Expeditions Holdings
UTK.X0.0449510.001103
+2.52%
xMoney cryptocurrency
AKRO26.960.32
+1.20%
Akero Therapeutics
SF89.980.39
+0.44%
Stifel Financial Corp
BCAB1.66-0.02
-1.19%
BioAtla